Search results
Results from the WOW.Com Content Network
Though listed as a synonym for the National Library of Medicine MeSH term "Outcome Assessment (Health Care)", [1] outcomes research may refer to both health services research and healthcare outcomes assessment, which aims at health technology assessment, decision making, and policy analysis through systematic evaluation of quality of care ...
ISPOR—The Professional Society for Health Economics and Outcomes Research, also known as ISPOR (and formerly as the International Society for Pharmacoeconomics and Outcomes Research) is a global, nonprofit 501(c)(3) public organization for educational and scientific purposes, as defined by the United States Internal Revenue Service.
Routine health outcomes measurement is the process of examining whether or not interventions are associated with change (for better or worse) in the patient's health status. This change can be directly measured (e.g. by rating scales used by the clinician or patient) or assumed by the use of proxy measurement (e.g. a blood test result).
PCORI funds research studies that focus on patient-centered outcomes rather than only on CER alone. [9] [10] [2] Patient-centered outcomes research involves questions and outcomes that are "meaningful and important to patients and caregivers" [11] in order to help those individuals make informed decisions for their own care.
The RAND Health Insurance Experiment (RAND HIE) was an experimental study from 1974 to 1982 of health care costs, utilization and outcomes in the United States, which assigned people randomly to different kinds of plans and followed their behavior.
An outcome measure, endpoint, effect measure or measure of effect is a measure within medical practice or research, (primarily clinical trials) which is used to assess the effect, both positive and negative, of an intervention or treatment. [1] [2] Measures can often be quantified using effect sizes. [3]
How and why the drugs have such wide-ranging health benefits is subject to further research, and the GLP-1 drugs were found to increase risks of some conditions, including kidney stones and low ...
Linda H. Aiken, Ph.D., FAAN, FRCN, RN (born July 29, 1943) is an American nurse and researcher who is currently the Founding Director for the Center for Health Outcomes and Policy Research and a Senior Fellow of the Leonard Davis Institute for Health Economics.